FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979462806> ?p ?o ?g. }

• W2979462806 endingPage "10" @default.
• W2979462806 startingPage "1" @default.
• W2979462806 abstract "Objective . To evaluate the efficacy of high-flow nasal cannula (HFNC) therapy compared with conventional oxygen therapy (COT) or noninvasive ventilation (NIV) for the treatment of acute respiratory failure (ARF) in emergency departments (EDs). Method . We comprehensively searched 3 databases (PubMed, EMBASE, and the Cochrane Library) for articles published from database inception to 12 July 2019. This study included only randomized controlled trials (RCTs) that were conducted in EDs and compared HFNC therapy with COT or NIV. The primary outcome was the intubation rate. The secondary outcomes were the mortality rate, intensive care unit (ICU) admission rate, ED discharge rate, need for escalation, length of ED stay, length of hospital stay, and patient dyspnea and comfort scores. Result . Five RCTs ( n = 775) were included. There was a decreasing trend regarding the application of HFNC therapy and the intubation rate, but the difference was not statistically significant (RR, 0.53; 95% CI, 0.26–1.09; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.08</mml:mn></mml:mrow></mml:math>; I 2 = 0%). We found that compared with patients who underwent COT, those who underwent HFNC therapy had a reduced need for escalation (RR, 0.41; 95% CI, 0.22–0.78; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.006</mml:mn></mml:mrow></mml:math>; I 2 = 0%), reduced dyspnea scores (MD −0.82, 95% CI −1.45 to −0.18), and improved comfort (SMD −0.76 SD, 95% CI −1.01 to −0.51). Compared with the COT group, the HFNC therapy group had a similar mortality rate (RR, 1.25; 95% CI, 0.79–1.99; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.34</mml:mn></mml:mrow></mml:math>; I 2 = 0%), ICU admission rate (RR, 1.11; 95% CI, 0.58–2.12; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M4><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.76</mml:mn></mml:mrow></mml:math>; I 2 = 0%), ED discharge rate (RR, 1.04; 95% CI, 0.63–1.72; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M5><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.87</mml:mn></mml:mrow></mml:math>; I 2 = 0%), length of ED stay (MD 1.66, 95% CI −0.95 to 4.27), and hospital stay (MD 0.9, 95% CI −2.06 to 3.87). Conclusion . Administering HFNC therapy in ARF patients in EDs might decrease the intubation rate compared with COT. In addition, it can decrease the need for escalation, decrease the patient’s dyspnea level, and increase the patient’s comfort level compared with COT." @default.
• W2979462806 created "2019-10-18" @default.
• W2979462806 creator A5014432716 @default.
• W2979462806 creator A5015558988 @default.
• W2979462806 creator A5021306957 @default.
• W2979462806 creator A5022426107 @default.
• W2979462806 creator A5025934954 @default.
• W2979462806 creator A5026282888 @default.
• W2979462806 creator A5030688139 @default.
• W2979462806 creator A5054748899 @default.
• W2979462806 creator A5056784837 @default.
• W2979462806 creator A5065696059 @default.
• W2979462806 creator A5069734898 @default.
• W2979462806 date "2019-10-13" @default.
• W2979462806 modified "2023-10-14" @default.
• W2979462806 title "Use High-Flow Nasal Cannula for Acute Respiratory Failure Patients in the Emergency Department: A Meta-Analysis Study" @default.
• W2979462806 cites W170997490 @default.
• W2979462806 cites W1946843368 @default.
• W2979462806 cites W1969930920 @default.
• W2979462806 cites W1975803576 @default.
• W2979462806 cites W2002965500 @default.
• W2979462806 cites W2005501262 @default.
• W2979462806 cites W2041987026 @default.
• W2979462806 cites W2051533089 @default.
• W2979462806 cites W2063853377 @default.
• W2979462806 cites W2103016141 @default.
• W2979462806 cites W2103870669 @default.
• W2979462806 cites W2104701045 @default.
• W2979462806 cites W2115412499 @default.
• W2979462806 cites W2119905253 @default.
• W2979462806 cites W2148218430 @default.
• W2979462806 cites W2162360797 @default.
• W2979462806 cites W2165010366 @default.
• W2979462806 cites W2167917082 @default.
• W2979462806 cites W2170892587 @default.
• W2979462806 cites W2172882542 @default.
• W2979462806 cites W2172961117 @default.
• W2979462806 cites W2199023581 @default.
• W2979462806 cites W2331306740 @default.
• W2979462806 cites W2402357922 @default.
• W2979462806 cites W2465215050 @default.
• W2979462806 cites W2514367531 @default.
• W2979462806 cites W2528870556 @default.
• W2979462806 cites W2554939533 @default.
• W2979462806 cites W2574661803 @default.
• W2979462806 cites W2626406916 @default.
• W2979462806 cites W2740445742 @default.
• W2979462806 cites W2781688961 @default.
• W2979462806 cites W2809640926 @default.
• W2979462806 cites W2898018304 @default.
• W2979462806 cites W2908596328 @default.
• W2979462806 cites W2919469264 @default.
• W2979462806 cites W2920797638 @default.
• W2979462806 cites W2923561136 @default.
• W2979462806 doi "https://doi.org/10.1155/2019/2130935" @default.
• W2979462806 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6815584" @default.
• W2979462806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31737365" @default.
• W2979462806 hasPublicationYear "2019" @default.
• W2979462806 type Work @default.
• W2979462806 sameAs 2979462806 @default.
• W2979462806 citedByCount "8" @default.
• W2979462806 countsByYear W29794628062020 @default.
• W2979462806 countsByYear W29794628062021 @default.
• W2979462806 countsByYear W29794628062022 @default.
• W2979462806 countsByYear W29794628062023 @default.
• W2979462806 crossrefType "journal-article" @default.
• W2979462806 hasAuthorship W2979462806A5014432716 @default.
• W2979462806 hasAuthorship W2979462806A5015558988 @default.
• W2979462806 hasAuthorship W2979462806A5021306957 @default.
• W2979462806 hasAuthorship W2979462806A5022426107 @default.
• W2979462806 hasAuthorship W2979462806A5025934954 @default.
• W2979462806 hasAuthorship W2979462806A5026282888 @default.
• W2979462806 hasAuthorship W2979462806A5030688139 @default.
• W2979462806 hasAuthorship W2979462806A5054748899 @default.
• W2979462806 hasAuthorship W2979462806A5056784837 @default.
• W2979462806 hasAuthorship W2979462806A5065696059 @default.
• W2979462806 hasAuthorship W2979462806A5069734898 @default.
• W2979462806 hasBestOaLocation W29794628061 @default.
• W2979462806 hasConcept C11413529 @default.
• W2979462806 hasConcept C118552586 @default.
• W2979462806 hasConcept C126322002 @default.
• W2979462806 hasConcept C141071460 @default.
• W2979462806 hasConcept C2776478404 @default.
• W2979462806 hasConcept C2778074680 @default.
• W2979462806 hasConcept C2778716859 @default.
• W2979462806 hasConcept C2780334268 @default.
• W2979462806 hasConcept C2780630273 @default.
• W2979462806 hasConcept C2780724011 @default.
• W2979462806 hasConcept C41008148 @default.
• W2979462806 hasConcept C42219234 @default.
• W2979462806 hasConcept C71924100 @default.
• W2979462806 hasConcept C95190672 @default.
• W2979462806 hasConceptScore W2979462806C11413529 @default.
• W2979462806 hasConceptScore W2979462806C118552586 @default.
• W2979462806 hasConceptScore W2979462806C126322002 @default.
• W2979462806 hasConceptScore W2979462806C141071460 @default.
• W2979462806 hasConceptScore W2979462806C2776478404 @default.
• W2979462806 hasConceptScore W2979462806C2778074680 @default.

• next